Manifestations of pulmonary aspergillosis in pediatrics

Area of Science:

• Medical Mycology
• Pulmonology
• Infectious Diseases

Background:

• Aspergillus species cause a range of lung diseases, with severity linked to immune status and host response.
• Chronic pulmonary aspergillosis (CPA) includes conditions like aspergilloma, nodules, chronic cavitary, and fibrosing forms.
• Allergic bronchopulmonary aspergillosis (ABPA) is an immune response in asthma or cystic fibrosis patients.

Purpose of the Study:

• To review the current literature on chronic pulmonary aspergillosis and allergic bronchopulmonary aspergillosis.
• To highlight the increasing prevalence of these chronic Aspergillus conditions compared to invasive forms.
• To identify the need for further research into clinical significance and treatment options.

Main Methods:

• Literature review of recent research on chronic and allergic forms of pulmonary aspergillosis.
• Analysis of findings regarding Aspergillus colonization as a precursor to various lung diseases.
• Assessment of current knowledge gaps in treatment strategies, particularly for ABPA.

Main Results:

• Chronic Aspergillus conditions are becoming more prevalent than invasive Aspergillus infections.
• Aspergillus colonization may precede airway infections, chronic disease, or invasive disease.
• Limited high-level research exists on the clinical significance and treatment of these chronic conditions, with few advances in ABPA treatment assessment.

Conclusions:

• There is a critical need for more research on the clinical significance and treatment of chronic pulmonary aspergillosis and ABPA.
• Understanding Aspergillus colonization is key to managing subsequent lung diseases.
• Current treatment options and assessment methods for ABPA require significant advancement.